Vaxart, Inc. VXRT Cash Flow

Vaxart, inc. (VXRT)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash flows from operating activities:
Net loss
-18,603	-18,645	-17,138	-18,426	-21,660	-18,007	-16,505	-15,257	-9,924	-15,034	-20,734	-25,434	-28,896	-31,300	-28,800	-25,400	-38,300	-31,900	-18,800	-19,100	-9,400	-7,400	-14,000	-11,000	-7,300	-10,300	-5,600	-8,900	-5,133	-5,769	-21,699	-14,421	-16,287	-13,871	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Bargain purchase gain
-	-	-	-	-	6,760	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
3,076	3,596	3,678	3,863	3,792	3,203	2,464	1,614	794	380	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Gain) loss on sale of equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-47	0	0	0
Income from discontinued operations, net of tax provision
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Net loss from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-10,240	-9,054	-10,920	-7,513	0	0	0
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,100	2,100	2,200	2,300	2,400	2,000	2,500	2,900	3,000	2,417	1,534	2,131	1,551	1,579	1,627	0	0	0
Non-cash intra-period tax allocation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Stock-based compensation
559	627	642	679	617	539	687	1,004	1,015	1,053	1,253	1,153	1,424	1,700	1,800	2,000	2,100	2,300	2,300	2,100	1,900	1,800	1,800	1,700	1,700	1,600	2,700	2,600	2,958	3,534	1,317	1,913	1,900	1,494	0	0	0
Loss on revaluation of financial instruments
-	-	-	-	-	-3	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of discount on short-term investments
-	-	-	-	-	-	-	-	-	24	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss (gain) on revaluation of financial instruments, net
-	-	-	-	-	-	-	-	-	3,347	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest expense
-	88	133	146	160	448	1,047	1,643	2,229	2,557	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of note discount
-	-	-	-	-	18	55	91	126	144	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash royalty revenue related to sale of future royalties
-	-	-	-	-	-	-	-	-	-	3,300	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest expense related to sale of future royalties
2,020	2,073	2,121	2,153	2,105	1,859	1,698	1,566	1,498	1,700	1,800	1,800	1,700	1,200	700	300	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest expense related to sale of future royalties
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash revenue related to sale of future royalties
4,867	3,482	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,500	0	0	0	-	-	-	-	-	-
Change in operating assets and liabilities:
Accounts receivable
-2,921	1,823	303	-526	-7,765	-13,500	-14,840	-15,035	-3,522	-805	395	895	-7,230	-3,000	-2,500	-11,900	-2,900	-11,700	-15,000	-6,200	-24,000	-11,600	4,500	7,100	20,800	15,500	5,000	4,200	0	0	0	-	-	-	-	-	-
Receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-892	-726	-6,352	-35	0	0	0
Prepaid expenses and other assets
-65	-855	293	-105	304	873	616	248	119	-163	-1,463	137	1,587	1,300	3,100	2,100	500	500	300	-100	100	100	-700	-1,400	-1,100	-1,700	-400	600	483	904	1,146	-75	228	538	0	0	0
Accounts payable
67	-62	-153	-872	-871	-3,784	-2,894	-3,169	-3,232	-1,559	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other accrued liabilities
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued liabilities
-	-	-	-	-	-6,393	-6,535	-5,945	-5,782	-77	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable, accrued expenses and other liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,428	-5,244	-4,283	-5,858	0	0	0
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-300	-500	-700	-200	-100	-431	-863	-379	-910	-3,546	-6,181	0	0	0
Accounts payable and accrued expenses
-	-	-	-	-	-	-	-	-	-4,600	-3,900	-3,300	-3,400	3,500	1,300	-700	3,200	-4,900	-12,400	-15,800	-19,000	-7,300	5,900	10,600	14,900	6,800	-900	2,800	0	0	0	-	-	-	-	-	-
Accrued severance obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-800	-1,000	-3,600	-2,900	-3,200	-2,400	0	0	0	-	-	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-14,100	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in operating activities
-11,645	-13,090	-15,000	-16,030	-8,611	-14,548	-13,546	-12,688	-21,537	-15,223	-19,523	-25,723	0	0	0	-	-	-	-	-	0	0	0	-	-11,400	-15,700	-14,900	-13,900	-18,625	-16,540	-16,522	-16,750	-14,953	-22,041	0	0	0
Cash flows from investing activities:
Purchase of property and equipment
302	850	1,033	1,079	1,119	707	553	361	178	117	0	0	0	-	-	-	-	-	-	-	-	-	-	100	700	700	900	1,000	0	0	0	-	-	-	-	-	-
Call redemption of long-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,900	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sales and maturities of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,023	16,668	54,868	66,624	0	0	0
Proceeds from sale of equipment
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash acquired in reverse merger
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash acquired in reverse merger
-	-	-	-	-	25,525	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for fractional shares in merger
-	-	-	-	-	21	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of short-term investments
-	-	-	-	-	573	573	7,573	8,908	12,765	21,165	14,165	14,630	17,300	14,100	15,300	21,300	14,200	9,000	17,700	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from maturities of short-term investments
-	-	-	-	-	1,988	16,488	29,888	32,286	33,963	29,163	22,663	21,465	23,700	22,000	16,100	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,300	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-299	-850	-1,033	-1,079	-1,119	26,212	40,907	47,480	48,726	21,103	7,903	8,403	0	0	0	-	-	-	-	-	0	0	0	-	-700	-700	31,800	31,700	32,199	34,379	-10,617	1,220	28,945	40,701	0	0	0
Net proceeds from issuance of securities in registered direct offering
9,175	2,540	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	663	0	0	0
Proceeds from issuance of common stock upon exercise of common stock warrants
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of short-term note
-	-	-	-	-	214	112	61	278	0	0	0	0	-	-	300	300	200	200	100	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock upon exercise of stock options
0	-	-	-	-	13	37	37	37	24	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of principal on secured promissory note payable to Oxford Finance
-	3,799	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	17,800	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
33,379	15,960	17,669	9,446	659	-1,729	-1,210	-742	-265	0	0	0	0	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	663	0	0	0
Net increase (decrease) in cash and cash equivalents
21,435	2,020	1,636	-7,663	-9,071	9,935	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	5,880	-11,720	-17,420	2,380	-900	600	5,000	-30,700	-21,200	-7,000	-29,100	-11,800	14,500	-1,800	13,400	14,700	-16,400	16,900	17,800	13,574	17,839	-27,260	-15,530	14,222	19,185	0	0	0
Effects of exchange rate movements on cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7,900	-6,800	-2,200	-1,300	1,500	-4,900	-6,300	-3,200	-4,800	0	0	0	-	-	-	-	-	-
Supplemental disclosure of cash flow information:
Interest paid
-	227	275	303	333	356	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock on merger
9,175	2,540	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	663	0	0	0
Cash acquired on merger
-	-	-	-	-	25,525	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosure of non-cash financing activity:
Issuance of warrants to placement agent’s representatives
453	100	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of common stock upon reverse merger, net of cash paid for partial shares
-	-	-	-	-	31,768	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of convertible promissory notes, related parties into common stock upon reverse merger
-	-	-	-	-	35,577	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of common stock upon reverse merger, net of cash paid for partial shares
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of convertible promissory notes, related parties into common stock upon reverse merger
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reclassification of convertible preferred stock warrant liability to equity
-	-	-	-	-	70	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease liabilities arising from obtaining right-of-use assets
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of property and equipment included in accounts payable
-	-	-	-	0	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-